News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
156,056 Results
Type
Article (7035)
Company Profile (13)
Press Release (149008)
Section
Business (55171)
Career Advice (339)
Deals (9758)
Drug Delivery (12)
Drug Development (22048)
Employer Resources (31)
FDA (3540)
Job Trends (3884)
News (87682)
Policy (6312)
Tag
Academia (488)
Africa (142)
Alabama (7)
Allergies (14)
Alliances (5693)
Alzheimer's disease (261)
Antibody-drug conjugate (ADC) (13)
Approvals (3527)
Arizona (22)
Artificial intelligence (9)
Asia (9690)
Australia (1381)
Bankruptcy (68)
Best Places to Work (3320)
Biosimilars (11)
C2C Services and Suppliers (13948)
California (173)
Canada (212)
Cancer (52)
Cardiovascular disease (7)
Career advice (280)
Cell therapy (12)
Clinical research (17832)
Collaboration (10)
COVID-19 (517)
CRISPR (8)
Cystic fibrosis (14)
Data (11)
Delaware (11)
Diabetes (8)
Diagnostics (1419)
Diversity, equity & inclusion (12)
Earnings (42223)
Employer resources (26)
Europe (21432)
Events (30728)
FDA (3544)
Florida (15)
Funding (7)
Gene editing (11)
Gene therapy (18)
GLP-1 (146)
Government (873)
Healthcare (4724)
Hotbed/Location (110759)
Idaho (7)
Illinois (31)
Indiana (43)
Infectious disease (518)
Inflammatory bowel disease (17)
Interviews (69)
IPO (6070)
Job creations (575)
Job search strategy (252)
Kansas (26)
Layoffs (101)
Legal (1153)
Liver cancer (17)
Lung cancer (13)
Maine (25)
Management (10)
Manufacturing (7)
Maryland (59)
Massachusetts (135)
Medical device (3117)
Medtech (3117)
Mergers & acquisitions (3640)
Metabolic disorders (46)
NASH (7)
Neuroscience (272)
New Jersey (18)
New York (22)
NextGen Class of 2024 (1308)
Non-profit (857)
North Carolina (29)
Obesity (29)
Opinion (28)
Patents (8)
Peanut (12)
Pennsylvania (11)
People (4795)
Phase I (4599)
Phase II (7415)
Phase III (7245)
Postmarket research (844)
Preclinical (1575)
Rare diseases (18)
Real estate (644)
Recruiting (8)
Regulatory (4439)
Reports (7)
Research institute (411)
Resumes & cover letters (51)
South America (241)
Startups (517)
Texas (17)
United States (714)
Vaccines (82)
Washington State (43)
Weight loss (35)
Date
Today (9)
Last 7 days (126)
Last 30 days (489)
Last 365 days (12290)
2024 (6790)
2023 (12819)
2022 (15347)
2021 (15099)
2020 (13778)
2019 (10992)
2018 (8211)
2017 (8222)
2016 (7145)
2015 (8991)
2014 (6198)
2013 (4618)
2012 (5210)
2011 (5393)
2010 (4871)
156,056 Results for "9".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announced the publication of a significant research article in the European Society of Medicine Journal. The study investigates the effects of CYP2C9 polymorphisms on the pharmacokinetics (“PK”) of delta-9-tetrahydrocannabinol (“THC”) and its active metabolite in Alzheimer’s disease (“AD”) patients.
June 10, 2024
·
5 min read
Pharm Country
Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024
HUTCHMED Limited announces that it will host a R&D update in Shanghai, China, and via webcast on Tuesday, July 9, 2024.
June 24, 2024
·
2 min read
Genetown
Axena Health closes on over $9 million in additional funding
Axena Health, Inc., a medical device company focused on female pelvic health, has closed on an additional $9.4 million in its Series A fundraising.
June 4, 2024
·
4 min read
Drug Development
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3202 in Patients with Locally Advanced or Metastatic Melanoma
Alpha-9 Oncology announced that the first participant has been dosed in the Phase 1 study evaluating 68Ga-A9-3202, a radiodiagnostic targeting melanocortin 1 receptor for the imaging of locally advanced or metastatic melanoma.
May 2, 2024
·
2 min read
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, announced the completion of the full exercise of 12.9 million Series H warrants.
July 1, 2024
·
6 min read
Biotech Beach
Simulations Plus Releases GastroPlus® Version 9.9
Simulations Plus, Inc. today announced the release of GastroPlus® 9.9, the latest version of its flagship physiologically based pharmacokinetics/biopharmaceutics (PBPK/PBBM) modeling and simulation software.
January 30, 2024
·
4 min read
ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited, the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, announced a non-exclusive CRISPR/Cas9 license agreement.
May 20, 2024
·
2 min read
Drug Development
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor
AstraZeneca on Wednesday unveiled Phase I results for its PCSK9 inhibitor, acquired from Dogma Therapeutics in 2020, which when combined with a statin reduced LDL-C levels in patients with high “bad” cholesterol.
May 29, 2024
·
2 min read
·
Tyler Patchen
Business
Cutera to Announce First Quarter Results on May 9, 2024
Cutera, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024.
April 26, 2024
·
1 min read
Press Releases
Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer
July 15, 2024
·
9 min read
1 of 15,606
Next